Nasser Sadr

Senior Director Global Analytical Development at uniQure

Speaker

Nasser Sadr is currently the Sr Director of Global Analytical Development at uniQure. In this role, he is involved in all aspects of AAV product development, and has actively contributed to the successful BLA filing of the first EU and US approved AAV hemophilia program, as well as to the development of multiple early clinical and pre-clinical products. Working across start up, SME, and corporate organizations he has gained over 15+ years industry experience in different areas of ATMP field. Nasser has been involved in cell and ex vivo gene therapy for over 6 years in a CDMO setting, supporting 13+ programs at different stages of clinical development. In 2019, he has transitioned to uniQure, where he has been focusing on AAV-based product. Nasser holds a PhD degree in Bioengineering from the Polytechnic of Milan, Italy.